Oculoplastic surgeons have been frustrated watching their patients with thyroid eye disease in active phase and not having an FDA-approved drug to help, Roger A. Dailey, MD, FACS, told Healio.com/OSN.
“Sometimes steroids help, but those have side effects,” he said, and physicians have to wait until their patients develop problems before turning to a surgical solution.
Proptosis, lid retraction, double vision and photosensitivity can be disabling consequences of thyroid eye disease, he said, but there is a potential “game changer” under review by the FDA. Teprotumumab
Uncategorized